Cluzeau, T., Robert, G., Mounier, N., Karsenti, J. M., Dufies, M., Puissant, A., . . . Auberger, P. (2012). BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients. Impact Journals LLC.
Chicago Style CitationCluzeau, Thomas, et al. BCL2L10 Is a Predictive Factor for Resistance to Azacitidine in MDS and AML Patients. Impact Journals LLC, 2012.
MLA CitationCluzeau, Thomas, et al. BCL2L10 Is a Predictive Factor for Resistance to Azacitidine in MDS and AML Patients. Impact Journals LLC, 2012.
Warning: These citations may not always be 100% accurate.